The plaintiff commenced a 468-page statement of claim against 38 defendants, alleging that her children's autism was caused by environmental toxins and acetaminophen, and seeking billions of dollars to fund a fecal microbiota transplant program.
A motion judge dismissed the claim against most defendants under Rule 2.1.01 as frivolous and vexatious, but allowed the claims against the Bayer and Johnson defendants to proceed.
The Bayer and Johnson defendants appealed.
The Divisional Court allowed the appeal, finding that the motion judge erred by failing to consider the plaintiff's lack of standing, the court's inability to order the requested research funding, and the numerous hallmarks of querulous litigation present in the claim.
The action was dismissed against the remaining defendants.